The US Food and Drug Administration pushes hospitals to streamline their process of reporting problems related to medical devices.
After receiving reports about the potential risk of using hysterectomy surgery devices, the FDA is said to be enhancing the agency’s current reporting system by determining how a medical device causes deaths or injuries. They are also looking at the possibility of forcing all hospitals to submit death and injury reports related to the issue.
The FDA is currently targeting laparoscopic morcellators following the death of a 51-year-old woman who died from uterine cancer. According to reports, the Brigham and Women’s Hospital did not report a case in which a power morcellator reportedly triggered the proliferation of cancer cells in the patient’s body. Meanwhile, the U.S. Government Accountability Office is currently conducting an investigation and will be releasing a report in January.
If you or someone you know has developed cancer after undergoing a surgery involving a power morcellator, get in touch with a lawyer from Williams Hart at (713) 352-7071.
There is a significant decrease in the use of power morcellators after the U.S. Food and Drug Administration (FDA) issued warning that the tissue chopped by morcellators could contain cancerous cells and may spread throughout the abdominal cavity.
Since the FDA released its new guidelines, the rate of new minimally invasive hysterectomies using power morcellators has been declining. In 2013, 14 percent of minimally invasive hysterectomies were performed using morcellators. The number dropped to just three percent in 2015.
Despite the advisory, some doctors still support the use of morcellators. Women need to be aware of the risks that morcellation carries.
If you have undergone a medical procedure involving a power morcellator and have developed cancer in the process, speak with the Morcellator lawsuit lawyers at Williams Hart by calling (713) 352-7071 and learn how to assert your rights and to hold negligent parties responsible.
A morcellator is a device used to trap cancerous tissue during hysterectomies and surgeries to remove fibroids. The devices resemble a drill with sharp blades at the end. Doctors insert the long, tube-like portion into small incisions in the abdomen, perform morcellation of the uterus or fibroid by chopping up the tissue, and vacuum it out of the body.
The use of morcellators has been linked to cancer growth in women. The U.S. Food and Drug Administration allowed an Irish company to market its new power morcellator tissue collection system. The bag promises to trap potentially cancerous tissue and prevent it from spreading in the body, but the new tool is not guaranteed to stop the spread of cancer.
If you have suffered from the aggressive growth of cancer after undergoing a medical procedure involving a power morcellator, please speak with the lawyers at Williams Hart. Call us today at (713) 352-7071 to learn more about your rights and to hold negligent parties responsible.
An increasing number of women who underwent laparoscopic procedure involving a power morcellatorhave been filing lawsuits over allegations that the device may spread undetected cancer in the uterus. Recent studies have suggested the prevalence of uterine cancer hidden in benign growths in the uterus, and using a power morcellator may thus trigger the spread of the cancer.
If you have recently been diagnosed with uterine fibroids, it is important to note that not all uterine fibroids should be removed. Growths that show no signs or symptoms and cause no complications may not require treatment and instead may only need watchful waiting. After all, uterine fibroids are known to grow slowly. They also seldom affect pregnancy, and can shrink after menopause.
At Williams Hart, we help women adversely affected by power morcellators file a lawsuit against the manufacturers. To find out whether your circumstances qualify you for a claim, call us at (713) 352-7071 today.
Power morcellators are devices used to remove non-cancerous uterine fibroids by breaking up the growths into pieces before retrieving it out of the body. Many gynecologists previously recommended the use of a power morcellator when treating uterine growths, despite the fact that uterine sarcoma could be hidden in these presumed benign fibroids.
Uterine sarcomas are cancer cells that develop in the muscles of the uterus or the tissues that support it. Although many assume uterine sarcoma as a rare occurrence, several studies have found that it is not as rare as it is believed to be. In fact, a 1990 study at a hospital in Los Angeles revealed that around 1 in 200 women who underwent uterine fibroid surgeries had hidden sarcoma. The results were later supported by two studies done in 1999 and 2008, which revealed ratios of one-in-462 and one-in-253, respectively.
Undergoing uterine fibroid surgery with a power morcellator can spread uterine sarcoma, thereby exacerbating the condition. At Williams Hart, we help power morcellator victims seek compensation from the manufacturers involved. Call us at (713) 352-7071 today.